Condition
Iron Malabsorption
Total Trials
4
Recruiting
1
Active
1
Completed
2
Success Rate
66.7%-20% vs avg
Key Insights
Highlights
Success Rate
67% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 64/100
Termination Rate
25.0%
1 terminated out of 4 trials
Success Rate
66.7%
-19.8% vs benchmark
Late-Stage Pipeline
25%
1 trials in Phase 3/4
Results Transparency
50%
1 of 2 completed with results
Key Signals
1 with results67% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (1)
P 2 (1)
P 4 (1)
Trial Status
Completed2
Recruiting1
Terminated1
Trial Success Rate
66.7%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT05340465Phase 2Recruiting
Darbe Plus IV Iron to Decrease Transfusions While Maintaining Iron Sufficiency in Preterm Infants
NCT03438227Phase 4Completed
Intravenous Iron for Iron-deficiency Anemia in Pregnancy: a Randomized Controlled Trial
NCT03548948Not ApplicableCompleted
Obesity, Iron Regulation and Colorectal Cancer Risk
NCT02036944Terminated
Celiac Disease and Unexplained Iron Deficiency in a Primary Care Setting
Showing all 4 trials